co-morbidities

INTEREST - 13th International Conference on HIV Treatment, Pathogenesis, and Prevention Research in Resource-Limited Settings

Venue
Accra, Ghana

Known as the “African CROI” the INTEREST Conference brings together scientists involved in HIV treatment, pathogenesis, and prevention research in Africa to share pivotal findings, promote collaboration, and transfer experiences across several fields and many continents. The conference will showcase cutting-edge knowledge in the diagnosis and treatment of HIV and the prevention of the HIV-1 infection.

Include in home page features rotation
Off

Webinar: The Double Burden: HIV and Cervical Cancer

Venue
Webinar

Women living with HIV are five times more likely to develop cervical cancer than HIV-negative women. To mark Cervical Cancer Awareness Month, we have partnered with Pink Ribbon Red Ribbon to host a webinar on Thursday, 26 January, presenting research on the link between HIV and cervical cancer, as well as integrated screening programmes.

Click here to register now for the webinar, featuring International AIDS Society President Linda-Gail Bekker.

Include in home page features rotation
Off

9th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2017)

Venue
Paris, France

The 9th IAS Conference on HIV Science (IAS 2017) will take place on 23-26 July 2017 at the Palais des Congrès in Paris, France. This biennial gathering is the largest open scientific conference on HIV and AIDS related issues - bringing together a broad cross-section of more than 6,000 professionals from around the world to meet and examine the latest scientific developments in HIV-related research with a focus on moving science into practice and policy.

Include in home page features rotation
Off

Request for proposals: Services to Conduct Comprehensive Assessment of HIV Co-infection/Co-Morbidities Landscape

Closing date

UNITAID is seeking qualified candidates to provide consultancy services to undertake acomprehensive assessment of the HIV co-infection/co-morbidities landscape.  Deadline for receipt of proposals is Friday 2 September 2016 at 5pm, Geneva time.

Visit http://unitaid.org/en/what/1590-rfp-2016-10 for all documents relating to this RFP.

Prisoners, prisons, and HIV: time for reform

Is the resource available on the Internet?
Yes
Author
Chris Beyrer, Adeeba Kamarulzaman, Martin McKee

Prisoners and detainees worldwide have higher burdens of HIV, viral hepatitis, and tuberculosis than the communities from which they come. This disease burden among prisoners has been recognised since the early years of these inter-related pandemics. Yet the health needs of prisoners receive little attention from researchers or advocates working to improve responses for these diseases, and scant funding for prevention or treatment interventions.

Include in home page features rotation
Off

Benefits of early HIV treatment are clear, but issues raised by START and D:A:D remain unresolved

Is the resource available on the Internet?
Yes
Author
Liz Highleyman

The long-running controversy over when to start antiretroviral therapy (ART) has been definitively answered, but research is still needed to fully understand the implications of the large START and D:A:D studies, Professor Jens Lundgren of the University of Copenhagen said yesterday at a joint plenary session of the 15th European AIDS Conference and the 17th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV.

Include in home page features rotation
Off

17th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV

Venue
Barcelona, Spain

Provisional outlines for plenary presentations at the 17th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV, including the joint session with the European AIDS Conference, are:

Include in home page features rotation
Off
Subscribe to co-morbidities